Streetbeat News

BTSG

BrightSpring Health Services Inc

Open

19.30

Mkt cap

3.4B

Volume

952K

High

19.67

P/E Ratio

-89.23

52-wk high

20.25

Low

18.86

Div yield

N/A

52-wk low

7.85

BrightSpring Health Services is set to acquire Haven Hospice for $60 million. This acquisition could impact the healthcare services market and related companies.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 8:35 pm

Goldman Sachs analyst Jamie Perse maintains a Buy rating on BrightSpring Health (NASDAQ:BTSG) but lowers the price target from $21 to $18.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 3:39 pm

BrightSpring Health Services shares are trading lower after the company reported worse-than-expected Q2 adjusted EPS results.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 12:37 pm

BrightSpring Health Services has increased its FY24 guidance, projecting net revenue between $10.45 billion and $10.90 billion, surpassing the previous estimate of $10.30 billion to $10.80 billion. The Pharmacy Segment is expected to see significant growth, with revenue between $8.00 billion and $8.40 billion, while the Provider Segment is projected to grow more modestly. Adjusted EBITDA is forecasted to be between $570 million and $580 million.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 10:48 am

BrightSpring Health (NASDAQ:BTSG) reported Q2 2024 earnings per share (EPS) of $0.10, missing the analyst estimate of $0.17 by 41.18%. However, the company reported sales of $2.730 billion, beating the estimate of $2.613 billion by 4.46%. EPS decreased by 33.33% year-over-year, while sales increased by 25.98%.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 10:06 am

BrightSpring Health has announced a definitive agreement to acquire the assets of Haven Hospice, a Florida-based company, for a total consideration of $60 million. The acquisition includes $15 million in cash, $30 million in company equity, and a $15 million seller note payable four years after closing.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 9:00 pm

BTIG initiates coverage on BrightSpring Health (NASDAQ:BTSG) with a Buy rating and sets a price target of $15.

Portfolio Pulse from Benzinga Newsdesk

June 21, 2024 | 10:21 am

BrightSpring Health Services has announced several recent tuck-in and strategic acquisitions aimed at driving geographic penetration, integrated care, and company growth.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2024 | 11:43 am

Analyst ratings for BrightSpring Health (NASDAQ:BTSG) show varied opinions, with recent adjustments reflecting a mix of bullish to bearish sentiments. The average 12-month price target has been adjusted to $16.77, down 18.2% from the previous $20.50, indicating a downward trend in expectations. BrightSpring Health's financial performance reveals a positive revenue growth of 20.5% as of December 31, 2023, but concerns about its high debt-to-equity ratio and below-average ROA. The company operates in home and community-based healthcare services, with significant revenue from its Pharmacy Solutions segment.

Portfolio Pulse from Benzinga Insights

May 06, 2024 | 8:00 pm

Wells Fargo analyst Stephen Baxter has maintained an Overweight rating on BrightSpring Health (NASDAQ:BTSG) and increased the price target from $15 to $16.

Portfolio Pulse from Benzinga Newsdesk

May 06, 2024 | 1:52 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.